TY - PAT
T1 - Combination Comprising Parthenolide For Use In The Treatment Of Alzheimer's Disease And Other Neurodegenerative Disorders
AU - Bajic, Vladimir B.
AU - Essack, Magbubah
N1 - KAUST Repository Item: Exported on 2019-02-13
PY - 2015/6/18
Y1 - 2015/6/18
N2 - The present invention generally concerns particular methods and compositions for treatment of a neurodegenerative disease, such as Alzheimer's Disease. In particular embodiments, there is a composition comprising Parthenolide and a second agent, including an inhibitor of TLR4/MD-2/CD14, nAChR agonist, Resatorvid, Curcumin, Tilorone or a Tilorone analog, or a combination thereof.
AB - The present invention generally concerns particular methods and compositions for treatment of a neurodegenerative disease, such as Alzheimer's Disease. In particular embodiments, there is a composition comprising Parthenolide and a second agent, including an inhibitor of TLR4/MD-2/CD14, nAChR agonist, Resatorvid, Curcumin, Tilorone or a Tilorone analog, or a combination thereof.
UR - http://hdl.handle.net/10754/594860
UR - http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220150164858%22.PGNR.&OS=DN/20150164858&RS=DN/20150164858
UR - http://assignment.uspto.gov/#/search?adv=publNum:20150164858
UR - http://www.google.com/patents/US20150164858
UR - http://worldwide.espacenet.com/publicationDetails/biblio?CC=US&NR=2015164858A1&KC=A1&FT=D
M3 - Patent
M1 - US 20150164858 A1
ER -